2Dapoigny M, Ahitbol JL, Fraitag B. Efficacy of peripheral kappa agonist fedotozlne versus placebo in treatment of irritable bowel syndrome. A multiceuter dose-response study[J]. Dig Dis Sci, 1995,40(10) : 2244 - 2249.
3Wingate D, Hongo M, Kellow J, et al. Working party report. Disorders of gastrointestinal motility:Towards a new classification [ J ]. J of Gastroenterology and Hepatology, 2002,17 ( Suppl ): 1 - 14.
4Dmssman, DA, Corasziari E, Talley N J, et al . Rome II : The functional gastrointestinal disorders[M]. 2nd ed. McLean, Virginia: Degnon and Associates. 2000.
5Tsubouchi T, Saito T, Mizutani F, et al. Stimulatory Action of Itopride Hydrochlofide on Colonic Motor Activity In Vitro and In Vivo[J]. J Pharmacol Exp Ther,2003, Apt 30 ; [epub ahead of print].
6McRoberts JA, Coutinho SV, Marvizon JC, Grady EF,Tognetto M, Sengupta JN, Ennes HS, Chaban VV,Amadesi S, Creminon C, Lanthorn T, Geppetti P, Bunnett NW, Mayer EA. Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Ga
7Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology, 2000, 119: 1276-1285.
8Chan YK, Herkes GK, Badcock C, Evans PR, Bennett E,Kellow JE. Alterations in cerebral potentials evoked by rectal distension in irritable bowel syndrome. Am J Gastroenterol, 2001, 96: 2413-2417.
9Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain, 2000, 4: 5-15.
10Bradesi S, Eutamene H, Fioramonti J, Bueno L. Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids. Gut, 2002,50: 349-354.
